Market News

Will Today’s BidaskScore Upgrade Google Mirati Therapeutics (NASDAQ:MRTX) Shares?

Will Today’s BidaskScore Upgrade Google Mirati Therapeutics (NASDAQ:MRTX) Shares?

Investors sentiment decreased to 1.11 in 2018 Q4. Its down 1.06, from 2.17 in 2018Q3. It turned negative, as 28 investors sold Mirati Therapeutics, Inc. shares while 26 reduced holdings. 22 funds opened positions while 38 raised stakes. 29.96 million shares or 6.78% more from 28.05 million shares in 2018Q3 […]

Analysts at BidaskScore Give Marriot Vacations Worldwide (NYSE:VAC) a Downgrade

Analysts at BidaskScore Give Marriot Vacations Worldwide (NYSE:VAC) a Downgrade

Investors sentiment decreased to 0.83 in Q4 2018. Its down 2.36, from 3.19 in 2018Q3. It dropped, as 67 investors sold Marriot Vacations Worldwide Cor shares while 74 reduced holdings. 38 funds opened positions while 79 raised stakes. 38.27 million shares or 47.44% less from 72.81 million shares in 2018Q3 […]

Should Investors Turn Their Attention to Lexington Realty Trust (NYSE:LXP)? BidaskScore Has Just Upgraded the Stock

Should Investors Turn Their Attention to Lexington Realty Trust (NYSE:LXP)? BidaskScore Has Just Upgraded the Stock

Investors sentiment increased to 1.14 in 2018 Q4. Its up 0.18, from 0.96 in 2018Q3. It is positive, as 17 investors sold Lexington Realty Trust shares while 73 reduced holdings. 45 funds opened positions while 58 raised stakes. 173.05 million shares or 0.09% less from 173.21 million shares in 2018Q3 […]

Is Lexington Realty Trust (NYSE:LXP) now a ‘Buy’ After a BidaskScore Upgrade?

Is Lexington Realty Trust (NYSE:LXP) now a ‘Buy’ After a BidaskScore Upgrade?

Investors sentiment increased to 1.14 in Q4 2018. Its up 0.18, from 0.96 in 2018Q3. It increased, as 17 investors sold Lexington Realty Trust shares while 73 reduced holdings. 45 funds opened positions while 58 raised stakes. 173.05 million shares or 0.09% less from 173.21 million shares in 2018Q3 were […]

Should Investors Head For The Exit? BidaskScore Downgrades Five Below (NASDAQ:FIVE)

Should Investors Head For The Exit? BidaskScore Downgrades Five Below (NASDAQ:FIVE)

Investors sentiment increased to 1.22 in 2018 Q4. Its up 0.21, from 1.01 in 2018Q3. It increased, as 50 investors sold Five Below, Inc. shares while 100 reduced holdings. 72 funds opened positions while 111 raised stakes. 53.98 million shares or 4.30% more from 51.76 million shares in 2018Q3 were […]

Hancock Jaffe Laboratories, Inc. filed on Thursday, May 09 10-Q Form

Hancock Jaffe Laboratories, Inc. revealed 10-Q form on Thu, May 09 accessible here. The Company computes basic and diluted loss per share by dividing net loss attributable to common stockholders by the weighted average number of common stock outstanding during the period. Net loss attributable to common stockholders consists of […]

AMICUS THERAPEUTICS, INC. filed on Thu, May 09 10-Q

AMICUS THERAPEUTICS, INC. revealed 10-Q form on Thursday, May 09. In September 2018, the Company entered into a loan agreement with BioPharma Credit PLC as the lender. The loan agreement provides for a $150 million senior secured term loan (“Senior Secured Term Loan”) with an interest rate equal to the […]

BidaskScore Hits Adaptimmune Therapeutics (NASDAQ:ADAP) Hard With Today’s Downgrade

BidaskScore Hits Adaptimmune Therapeutics (NASDAQ:ADAP) Hard With Today’s Downgrade

Adaptimmune Therapeutics (NASDAQ:ADAP) Receives a Downgrade The past rating for shares of Adaptimmune Therapeutics (NASDAQ:ADAP) is now invalid as BidaskScore has lowered Adaptimmune Therapeutics (NASDAQ:ADAP)‘s stock rating to a “Sell”. The stock decreased 0.46% or $0.02 during the last trading session, reaching $4.3. About 460,721 shares traded or 46.57% up […]